Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2014-10-02

Clinical Trial Update: MRI and Bladder Cancer Chemotherapy

View source ↗

Summary

A clinical trial investigating MRI-guided techniques with chemotherapy for invasive bladder cancer has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: NYU Langone Health | Conditions: Invasive Bladder Cancer | Status: WITHDRAWN